DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.
Corboy JR, Fox RJ, Cutter G, Engebretson E, Miller A, Morgan C, Gustafson T, Goodman AD, Kannan M, Sriram S, Xia Z, Lynch S, Bowen J, Kister I.
Corboy JR, et al. Among authors: fox rj.
Mult Scler. 2025 Jan 21:13524585241303489. doi: 10.1177/13524585241303489. Online ahead of print.
Mult Scler. 2025.
PMID: 39834328